🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could result in individuals administering products of unknown origin.

Several experts stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

Based on TikTok, the service has removed violative material and banned related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with numerous of users, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or injecting at residence.

After moments of joining one group, a vendor posted contact information, where most transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these groups, posts show black plastic packages with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they can’t verify. Even if the science behind this drug is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously seen patients injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental product not yet authorized … may subject users to potentially serious health risks”.